{"id":4656,"date":"2016-11-11T10:45:14","date_gmt":"2016-11-11T09:45:14","guid":{"rendered":"https:\/\/encore-expertisecentrum.nl\/?p=4656"},"modified":"2020-12-11T08:11:23","modified_gmt":"2020-12-11T07:11:23","slug":"rate-trial","status":"publish","type":"post","link":"https:\/\/encore-expertisecentrum.nl\/en\/rate-trial\/","title":{"rendered":"RATE TRIAL"},"content":{"rendered":"<p>Fase 2 en 3 klinische studie naar het effect van het medicijn Sirolimus in kinderen met TSC.<\/p>\n\n\n\n<p>In this study, designed and conducted by ENCORE, the effect of the drug Sirolimus on reducing seizures in TSC patients was tested. A total of 23 participants took part, including a number of TSC patients from the ENCORE expertise center. The study has been completed and the results were published in 2016.<\/p>\n\n\n\n<p>Overwater IE, <em>et al.<\/em> (2016) <strong>Sirolimus for epilepsy in children with tuberous sclerosis complex.<\/strong> <em>Neurology<\/em>. 87; 1011\u20138. <span style=\"text-decoration: underline;\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27511181\/\" target=\"_blank\" rel=\"noreferrer noopener\">Pubmed<\/a><\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Fase 2 en 3 klinische studie naar het effect van het medicijn Sirolimus in kinderen met TSC.<\/p>","protected":false},"author":5,"featured_media":4686,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[48],"tags":[],"_links":{"self":[{"href":"https:\/\/encore-expertisecentrum.nl\/en\/wp-json\/wp\/v2\/posts\/4656"}],"collection":[{"href":"https:\/\/encore-expertisecentrum.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/encore-expertisecentrum.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/encore-expertisecentrum.nl\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/encore-expertisecentrum.nl\/en\/wp-json\/wp\/v2\/comments?post=4656"}],"version-history":[{"count":3,"href":"https:\/\/encore-expertisecentrum.nl\/en\/wp-json\/wp\/v2\/posts\/4656\/revisions"}],"predecessor-version":[{"id":4805,"href":"https:\/\/encore-expertisecentrum.nl\/en\/wp-json\/wp\/v2\/posts\/4656\/revisions\/4805"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/encore-expertisecentrum.nl\/en\/wp-json\/wp\/v2\/media\/4686"}],"wp:attachment":[{"href":"https:\/\/encore-expertisecentrum.nl\/en\/wp-json\/wp\/v2\/media?parent=4656"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/encore-expertisecentrum.nl\/en\/wp-json\/wp\/v2\/categories?post=4656"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/encore-expertisecentrum.nl\/en\/wp-json\/wp\/v2\/tags?post=4656"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}